[PHARMA] YoY Quarter Result on 31-Mar-2024 [#1]

Announcement Date
27-May-2024
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2024
Quarter
31-Mar-2024 [#1]
Profit Trend
QoQ- 178.38%
YoY- 868.5%
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 964,959 880,454 962,174 793,499 819,921 786,108 617,923 7.70%
PBT 39,044 9,193 37,439 31,524 30,880 30,243 28,707 5.25%
Tax -12,865 -6,427 -8,583 -8,696 -8,465 -10,595 -11,118 2.45%
NP 26,179 2,766 28,856 22,828 22,415 19,648 17,589 6.84%
-
NP to SH 25,646 2,648 27,734 23,136 22,399 19,617 17,586 6.48%
-
Tax Rate 32.95% 69.91% 22.93% 27.59% 27.41% 35.03% 38.73% -
Total Cost 938,780 877,688 933,318 770,671 797,506 766,460 600,334 7.72%
-
Net Worth -272,392 -142,812 413,947 355,919 350,047 528,825 524,838 -
Dividend
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Div - - 10,479 10,468 15,673 15,630 12,991 -
Div Payout % - - 37.79% 45.25% 69.98% 79.68% 73.87% -
Equity
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Net Worth -272,392 -142,812 413,947 355,919 350,047 528,825 524,838 -
NOSH 1,441,229 1,310,208 1,309,126 261,705 261,229 260,505 259,821 33.01%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin 2.71% 0.31% 3.00% 2.88% 2.73% 2.50% 2.85% -
ROE 0.00% 0.00% 6.70% 6.50% 6.40% 3.71% 3.35% -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
RPS 66.95 67.20 73.45 303.20 313.87 301.76 237.83 -19.02%
EPS 1.78 0.20 2.12 8.84 8.57 7.53 6.77 -19.94%
DPS 0.00 0.00 0.80 4.00 6.00 6.00 5.00 -
NAPS -0.189 -0.109 0.316 1.36 1.34 2.03 2.02 -
Adjusted Per Share Value based on latest NOSH - 1,441,229
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
RPS 66.95 61.09 66.76 55.06 56.89 54.54 42.87 7.70%
EPS 1.78 0.18 1.92 1.61 1.55 1.36 1.22 6.49%
DPS 0.00 0.00 0.73 0.73 1.09 1.08 0.90 -
NAPS -0.189 -0.0991 0.2872 0.247 0.2429 0.3669 0.3642 -
Price Multiplier on Financial Quarter End Date
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Date 29/03/24 31/03/23 31/03/22 31/03/21 31/03/20 29/03/19 30/03/18 -
Price 0.355 0.285 0.755 3.26 1.26 2.27 4.28 -
P/RPS 0.53 0.42 1.03 1.08 0.40 0.75 1.80 -18.42%
P/EPS 19.95 141.02 35.66 36.88 14.69 30.14 63.23 -17.47%
EY 5.01 0.71 2.80 2.71 6.81 3.32 1.58 21.18%
DY 0.00 0.00 1.06 1.23 4.76 2.64 1.17 -
P/NAPS 0.00 0.00 2.39 2.40 0.94 1.12 2.12 -
Price Multiplier on Announcement Date
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Date 27/05/24 18/05/23 20/05/22 21/05/21 19/05/20 16/05/19 16/05/18 -
Price 0.39 0.38 0.72 4.03 1.88 2.36 4.07 -
P/RPS 0.58 0.57 0.98 1.33 0.60 0.78 1.71 -16.47%
P/EPS 21.92 188.02 34.01 45.59 21.93 31.34 60.13 -15.46%
EY 4.56 0.53 2.94 2.19 4.56 3.19 1.66 18.32%
DY 0.00 0.00 1.11 0.99 3.19 2.54 1.23 -
P/NAPS 0.00 0.00 2.28 2.96 1.40 1.16 2.01 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment